Control of prostate cancer associated with withdrawal of a supplement containing folic acid, L-methyltetrahydrofolate and vitamin B12: A case report

Journal of Medical Case Reports

Volumn 5, Issue , 2011, Pages

  Tisman, Glenn ^a   Garcia, April ^a  

^a Whittier Cancer Research Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5 METHYLTETRAHYDROFOLIC ACID; ANTINEOPLASTIC AGENT; BICALUTAMIDE; CAPECITABINE; CYANOCOBALAMIN; CYCLOPHOSPHAMIDE; DEUTASTERIDE; DIETHYLSTILBESTROL; DOCETAXEL; ESTRADIOL; ESTRAMUSTINE; FINASTERIDE; FLUTAMIDE; FOLIC ACID; HOMOCYSTEINE; HYDROCORTISONE; KETOCONAZOLE; LEUPRORELIN; NILANDRONE; PROSTATE SPECIFIC ANTIGEN; UNCLASSIFIED DRUG;

AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE SCINTISCANNING; CANCER CONTROL; CANCER DIAGNOSIS; CANCER RELAPSE; CANCER STAGING; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOLIC ACID BLOOD LEVEL; GLEASON SCORE; HUMAN; LOW DRUG DOSE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; PROSTATE BIOPSY; PROSTATE CANCER; SIDE EFFECT; TESTOSTERONE BLOOD LEVEL; TREATMENT RESPONSE; TREATMENT WITHDRAWAL; VITAMIN SUPPLEMENTATION;

EID: 80052029349     PISSN: None     EISSN: 17521947     Source Type: Journal    
DOI: 10.1186/1752-1947-5-413     Document Type: Article

References (30)

1. The influence of liver L. casei factor on spontaneous breast cancer in mice. Lewisohn R, Leuchtenberger C, Leuchtenberger R, Keresztesy JC, Science 1946 104 436 437 10.1126/science.104.2706.436 21001955
2. Experiments with pteroylglutamic acid and pteroylglutamic acid deficiency in human leukemia. Heinle R, Welch AD, J Clin Invest 1948 27 539 18935160
3. Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid (aminopterin). Farber S, Diamond LK, Mercer RD, Sylvester RF, Wolff JA, N Engl J Med 1948 238 787 793 10.1056/NEJM194806032382301 18860765
4. Studies on the role of folic acid in the leukemic process. Skipper HE, Chapman JB, Bell M, Cancer 1950 3 871 873 10.1002/1097-0142(1950)3:5<871:: AID-CNCR2820030514>3.0.CO;2-H 14772720
5. 12metabolism. Corcino JJ, Zalusky R, Greenberg M, Herbert V, Br J Haematol 1971 20 511 520 10.1111/j.1365-2141.1971.tb07066.x 4103047
6. Typical and atypical features of pernicious anemia. Green R, Thomas Addison and His Diseases Bristol: Society for Endocrinology and The Thomas Addison Society, Besser M, Bhatt R, James VHT, Keen H, 1994 1 377 390
7. 12modulation of prostate cancer growth and metabolism: a case report. Tisman G, Kutik S, Rainville C, J Med Case Reports 2009 3 9295 10.1186/1752-1947-3-9295 20062784
8. Folic acid and risk of prostate cancer: results from a randomized clinical trial. Figueiredo JC, Grau MV, Haile RW, Sandler RS, Summers RW, Bresalier RS, Burke CA, McKeown-Eyssen GE, Baron JA, J Natl Cancer Inst 2009 101 432 435 10.1093/jnci/djp019 19276452
9. Multivitamin use and risk of prostate cancer in the National Institutes of Health-AARP Diet and Health Study. Lawson KA, Wright ME, Subar A, Mouw T, Hollenbeck A, Schatzkin A, Leitzmann MF, J Natl Cancer Inst 2007 99 754 764 10.1093/jnci/djk177 17505071 (Pubitemid 47073522)
10. The extremely slow and variable activity of dihydrofolate reductase in human liver and its implications for high folic acid intake. Bailey SW, Ayling JE, Proc Natl Acad Sci USA 2009 106 15424 15429 10.1073/pnas.0902072106 19706381
11. Red blood cell folate vitamer distribution in healthy subjects is determined by the methylenetetrahydrofolate reductase C677T polymorphism and by the total folate status. Smulders YM, Smith DE, Kok RM, Teerlink T, Gellekink H, Vaes WH, Stehouwer CD, Jakobs C, J Nutr Biochem 2007 18 693 699 10.1016/j.jnutbio.2006.11.010 17418558 (Pubitemid 47385160)
12. Folic acid: vitamin and panacea or genetic time bomb? Lucock M, Yates Z, Nat Rev Genet 2005 6 235 240 10.1038/nrg1558 15738964 (Pubitemid 40293033)
13. 12deficiency: a case for the methylfolate trap. Smulders YM, Smith DE, Kok RM, Teerlink T, Swinkels DW, Stehouwer CD, Jakobs C, Br J Haematol 2006 132 623 629 10.1111/j.1365-2141.2005.05913.x 16445837 (Pubitemid 43381597)
14. The Genome Health Clinic and Genome Health Nutrigenomics concepts: diagnosis and nutritional treatment of genome and epigenome damage on an individual basis. Fenech M, Mutagenesis 2005 20 255 269 10.1093/mutage/gei040 15956042 (Pubitemid 41399465)
15. Dietary reference values of individual micronutrients and nutriomes for genome damage prevention: current status and a road map to the future. Fenech MF, Am J Clin Nutr 2010 91 1438S 1454S 10.3945/ajcn.2010.28674D 20219957
16. 12transport proteins, and risk of prostate cancer: a case-control study, systematic review, and meta-analysis. Collin SM, Metcalfe C, Refsum H, Lewis SJ, Zuccolo L, Smith GD, Chen L, Harris R, Davis M, Marsden G, Johnston C, Lane JA, Ebbing M, Bønaa KH, Nygård O, Ueland PM, Grau MV, Baron JA, Donovan JL, Neal DE, Hamdy FC, Smith AD, Martin RM, Cancer Epidemiol Biomarkers Prev 2010 19 1632 1642 10.1158/1055-9965.EPI-10-0180 20501771
17. 12, homocysteine, and folate-pathway polymorphisms with prostate-specific antigen velocity in men with localized prostate cancer. Collin SM, Metcalfe C, Refsum H, Lewis SJ, Smith GD, Cox A, Davis M, Marsden G, Johnston C, Lane JA, Donovan JL, Neal DE, Hamdy FC, Smith AD, Martin RM, Cancer Epidemiol Biomarkers Prev 2010 19 2833 2838 10.1158/1055-9965.EPI-10-0582 20852008
18. DNA methylation, cancer susceptibility, and nutrient interactions. Davis CD, Uthus EO, Exp Biol Med (Maywood) 2004 229 988 995 (Pubitemid 39431078)
19. Epigenetics in cancer: targeting chromatin modifications. Ellis L, Atadja PW, Johnstone RW, Mol Cancer Ther 2009 8 1409 1420 19509247
20. Multigene methylation analysis for detection and staging of prostate cancer. Enokida H, Shiina H, Urakami S, Igawa M, Ogishima T, Li LC, Kawahara M, Nakagawa M, Kane CJ, Carroll PR, Dahiya R, Clin Cancer Res 2005 11 6582 6588 10.1158/1078-0432.CCR-05-0658 16166436 (Pubitemid 41338998)
21. 12, and homocysteine and prostate cancer risk: a prospective study. Hultdin J, Van Guelpen B, Bergh A, Hallmans G, Stattin P, Int J Cancer 2005 113 819 824 10.1002/ijc.20646 15499634 (Pubitemid 40101265)
22. DNA hypomethylation arises later in prostate cancer progression than CpG island hypermethylation and contributes to metastatic tumor heterogeneity. Yegnasubramanian S, Haffner MC, Zhang Y, Gurel B, Cornish TC, Wu Z, Irizarry RA, Morgan J, Hicks J, DeWeese TL, Isaacs WB, Bova GS, De Marzo AM, Nelson WG, Cancer Res 2008 68 8954 8967 10.1158/0008-5472.CAN-07-6088 18974140
23. Mild folate deficiency induces genetic and epigenetic instability and phenotype changes in prostate cancer cells. Bistulfi G, VanDette E, Matsui SI, Smiraglia D, BMC Biol 2010 8 6 10.1186/1741-7007-8-6 20092614
24. Prostate cancer epigenetics: a review on gene regulation. Diaw L, Woodson K, Gillespie JW, Gene Regul Syst Bio 2007 1 313 325 19936097
25. High folic acid increases cell turnover and lowers differentiation and iron content in human HT29 colon cancer cells. Pellis L, Dommels Y, Venema D, Polanen A, Lips E, Baykus H, Kok F, Kampman E, Keijer J, Br J Nutr 2008 99 703 708 17868486 (Pubitemid 351351622)
26. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells. Kastl L, Brown I, Schofield AC, Int J Oncol 2010 36 1235 1241 20372798
27. Global DNA hypermethylation-associated cancer chemotherapy resistance and its reversion with the demethylating agent hydralazine. Segura-Pacheco B, Perez-Cardenas E, Taja-Chayeb L, Chavez-Blanco A, Revilla-Vazquez A, Benitez-Bribiesca L, Duenas-González A, J Transl Med 2006 4 32 10.1186/1479-5876-4-32 16893460 (Pubitemid 44437729)
28. Perspective of DNA methylation in cancer research. Ibrahim M, Int J Cancer Res 2010 6 188 201
29. Effects of testosterone on the metabolism of folate coenzymes in the rat. Rovinetti C, Bovina C, Tolomelli B, Marchettie M, Biochem J 1972 126 291 294 5071175
30. Cytoplasmic serine hydroxymethyltransferase mediates competition between folate-dependent deoxyribonucleotide and S-adenosylmethionine biosyntheses. Herbig K, Chiang EP, Lee LR, Hills J, Shane B, Stover PJ, J Biol Chem 2002 277 38381 38389 10.1074/jbc.M205000200 12161434 (Pubitemid 35154694)